SITC Archive Library

iSBTc 25th Annual Meeting 

02-26-2018 15:18

The International Society for Biological Therapy of Cancer (iSBTc) 25th Annual Meeting
October 2-4, 2010
Hyatt Regency Washington on Capitol Hill
Washington, DC

Program Organizers
Pierre Coulie, Md, PhD - de Duve Institute and University of Louvain
Elizabeth M. Jaffee, MD - Johns Hopkins University
Pawel Kalinski, MD, PhD - University of Pittsburgh Cancer Institute
Vernon K. Sondak, MD - H. Lee Moffitt Cancer Center

Program Summary
The iSBTc 25th Annual Meeting provides a multidisciplinary educational environment composed of cutting-edge research, oral presentations, poster presentations, and networking opportunities.

Target Audience
The target audience for these programs incorporates basic and clinical investigators from academic, regulatory and biopharmaceutical venues. The audience includes clinicians, researchers, students, post-doctoral fellows and allied health professionals.

Presentations and video recordings are available based on permission from presenters.


#Biomarkers #ClinicalTrials #BrainCancers #ProstateCancer #PresentationSlides #AnnualMeeting #CombinationTherapy #Cytokines #ImmuneCheckpointInhibitors #TherapeuticAntibodies #Vaccines #AlliedHealth #Clinician #Industry #Oncologist #Researcher #2010 #BladderCancer #ColonCancer #CervicalCancer
 #Melanoma #RenalCellCarcinoma #AdoptiveCellTherapy #Ipilimumab #AdverseEvents #Toxicities

Statistics
0 Favorited
19 Views
28 Files
0 Shares
49 Downloads
Attachment(s)
pdf file
New Insight and Opportunities   2.31 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Immune Checkpoint Blockade in Cancer Therapy: New Insight and Opportunities; Presenter: James P. Allison, PhD - Memorial Sloan-Kettering Cancer Center; Date: Saturday, October 2, 2010
pdf file
Therapeutic Vaccinations with Autologous mRNA Electropora...   843 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Therapeutic Vaccinations with Autologous mRNA Electroporated Dendritic Cells in Patients with Advanced Melanoma; Presenter: Bart Neyns, MD, PhD - Universitair Ziekenhuis Brussel; Date: Saturday, October 2, 2010
pdf file
Resistance to the Proapoptotic Effect of IFN-gamma on Mel...   1.11 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Resistance to the Proapoptotic Effect of IFN-gamma on Melanoma Cells Used in Patient-Specific Dendritic Cell Immunotherapy is Associated with Improved Overall Survival; Presenter: Andrew N. Cornforth, PhD - Noag Memorial Hospital Cancer Center; Date: Saturday, October 2, 2010
pdf file
IFN-gamma is Central to Both Immunogenic and Tolerogenic ...   563 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: IFN-gamma is Central to Both Immunogenic and Tolerogenic Properties of Dendritic Cells After IL-12 and GM-CSF Microsphere Treatment; Presenter: Jamie L. Harden - State University of New York, University of Buffalo; Date: Saturday, October 2, 2010
pdf file
The High-Dose Aldesleukin (IL-2) Select Trail in Patients...   393 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: The High-Dose Aldesleukin (IL-2) Select Trail in Patients with Metastatic Renal Cell Carcinoma; Presenter: Kim A. Margolin, MD - Seattle Cancer Care Alliance; Date: Saturday, October 2, 2010
pdf file
The Role of Invariant NKT Cells at the Interface of Innat...   1.11 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: The Role of Invariant NKT Cells at the Interface of Innate and Adaptive Immunity; Presenter: Vincenzo Cerundolo, MD, PhD - University of Oxford, Robert Lurie Comprehensive Cancer Center; Date: Saturday, October 2, 2010
pdf file
Friend or Foe?   1.97 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: T-Regulatory Cells in Colon Cancer: Friend or Foe?; Presenter: Khashayarsha Khazaie, PhD, DSc - Northwestern University, Robert Lurie Comprehensive Cancer Center; Date: Saturday, October 2, 2010
pdf file
Decoding the Tower of Babel   1022 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Decoding the Tower of Babel; Presenter: Vernon K. Sondak, MD - H. Lee Moffitt Cancer & Research Center; Date: Saturday, October 2, 2010
pdf file
Defining Response in Prostate Cancer Immunotherapy   919 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Defining Response in Prostate Cancer Immunotherapy; Presenter: Lawrence Fong, MD - University of California - San Francisco; Date: Saturday, October 2, 2010
pdf file
A New iSBTc Initiative   192 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Clinical Immunotherapy Guidelines: A New iSBTc Initiative; Presenter: Howard L. Kaufman, MD - Rush University Medical Center; Date: Saturday, October 2, 2010
pdf file
Therapeutic Vaccination Against HPV16-Induced Disease   2.98 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Therapeutic Vaccination Against HPV16-Induced Disease; Presenter: Cornelius J. M. Melief, MD, PhD - Leiden University Medical Center; Date: Sunday, October 3, 2010
pdf file
Induction of CD8+ T Cell Responses Against Novel Blioma-A...   3.31 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Induction of CD8+ T Cell Responses Against Novel Blioma-Associated Antigen Peptides and Clinical Activity by Vaccinations with alpha-Type-! Polarized Dendritic Cells and Poly-ICLC in Patients with Recurrent Malignant Glioma; Presenter: Hideho Okada, MD, PhD - University of Pittsburgh Cancer Institute; Date: Sunday, October 3, 2010
pdf file
Endogenous and Exogenous Vaccinations in the Context of I...   1.58 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Endogenous and Exogenous Vaccinations in the Context of Immunologic Checkpoint; Presenter: Jedd D. Wolchok, MD, PhD - Memorial Sloan-Kettering Cancer Center; Date: Sunday, October 3, 2010
pdf file
Vaccine Sites as Sinks and Graveyards for Tumor-specific ...   1.40 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Vaccine Sites as Sinks and Graveyards for Tumor-specific T Cells; Presenter: Willem W. Overwijk, PhD - University of Texas, MD Anderson Cancer Center; Date: Sunday, October 3, 2010
pdf file
Final Efficacy Results of A3671009, a Phase III Study of ...   783 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Final Efficacy Results of A3671009, a Phase III Study of Tremelimumab vs Chemotherapy in First-Line Patients with Unresectable Melanoma; Presenter: Antoni Ribas, MD - University of California, Los Angeles; Date: Sunday, October 3, 2010
pdf file
The Multkinase Inhibitor Sorafenib Reverses the Suppressi...   652 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: The Multkinase Inhibitor Sorafenib Reverses the Suppression of IL-12 and Enhancement of IL-10 by PGE2 in Murine Macrophages; Presenter: Leisha A. Emens, MD, PhD - Johns Hopkins University School of Medicine; Date: Sunday, October 3, 2010
pdf file
A Common Marker of Immunosuppression in Cancer Patients   1.10 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Loss of HLA-DR Expression on CD14+ Cells: A Common Marker of Immunosuppression in Cancer Patients; Presenter: Michael P. Gustafson, PhD - Mayo Clinic ; Date: Sunday, October 3, 2010
pdf file
Regulation of Anti-Tumor Immunity through Migration of Im...   1.07 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Regulation of Anti-Tumor Immunity through Migration of Immune Cell Subsets within the Tumor Microenvironment; Presenter: Thomas F. Gajewski, MD, PhD - University of Chicago ; Date: Sunday, October 3, 2010
pdf file
NCI Workshop on Prognostic and Predictive Immunologic Bio...   729 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Update: 2009 iSBTc/FDA/NCI Workshop on Prognostic and Predictive Immunologic Biomarkers in Cancer; Presenter: Lisa H. Butterfield, PhD - University of Pittsburgh; Date: Sunday, October 3, 2010
pdf file
Cancer Immunotherapy Trials Network Update - NCI   189 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Cancer Immunotherapy Trials Network Update - NCI; Presenter: William Merritt, PhD - National Cancer Institute; Date: Sunday, October 3, 2010
pdf file
Cancer Immunotherapy Trials Network Update   555 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Cancer Immunotherapy Trials Network Update; Presenter: Martin A. Cheever, MD - Fred Hutchinson Cancer Research Center; Date: Sunday, October 3, 2010
pdf file
Improving the Efficacy and Safety of G-M Virus-Specific T...   1.76 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Improving the Efficacy and Safety of G-M Virus-Specific T Cells for Solid Tumors; Presenter: Malcolm K. Brenner, MD, PhD - Baylor College of Medicine; Date: Monday, October 4, 2010
pdf file
Functional Reprogramming of the Tumor Stroma by IL-12 Eng...   679 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Functional Reprogramming of the Tumor Stroma by IL-12 Engineered T Cells is Required for Anti-Tumor Immunity; Presenter: Sid Kerkar, MD - National Cancer Institute, Center for Cancer Research, NIH; Date: Monday, October 4, 2010
pdf file
Noninvasive Positron Emission Tomography (PET) Imaging of...   1.88 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Noninvasive Positron Emission Tomography (PET) Imaging of Sleeping Beauty (SB) Modified CD19-Specific T Cells Expressed Herpes Simple Virus1-Thymidine Kinase; Presenter: Pallavi Raja Manuri, PhD - University of Texas, MD Anderson Cancer Center; Date: Monday, October 4, 2010
pdf file
Dissection of Therapy-Induced Melanoma-Reactive Cytotoxic...   1.36 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Dissection of Therapy-Induced Melanoma-Reactive Cytotoxic T Cell Responses; Presenter: Ton N. Schumacher, PhD - Netherlands Cancer Institute; Date: Monday, October 4, 2010
pdf file
Therapeutic Cell Engineering Using Surface-Conjugated Syn...   3.48 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Therapeutic Cell Engineering Using Surface-Conjugated Synthetic Nanoparticles; Presenter: Mattias Stephen, MD, PhD - Massachusetts Institute of Technology; Date: Monday, October 4, 2010
pdf file
Combination Opportunities in Immunotherapy with Immunstim...   2.56 MB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Combination Opportunities in Immunotherapy with Immunstimulatory mAb; Presenter: Ignacio Melero, MD, PhD - University of Navarra; Date: Monday, October 4, 2010
pdf file
Exploring Therapeutic Combinations with Anti-CTLA-4 Antibody   330 KB   1 version
Uploaded - 02-26-2018
Meeting: iSBTc 25th Annual Meeting; Presentation: Exploring Therapeutic Combinations with Anti-CTLA-4 Antibody; Presenter: Padmanee Sharma, MD, PhD - University of Texas, MD Anderson Cancer Center; Date: Monday, October 4, 2010